Early serial trough and antidrug antibody level measurements predict clinical outcome of infliximab and adalimumab treatment. Issue 2 (17th February 2011) - Vande Casteele, N; Ballet, V; Van Assche, G; Rutgeerts, P; Vermeire, S; Gils, A